NL-OMON37926
Completed
Not Applicable
Oral Paricalcitol versus Calcitriol in Peritoneal Dialysis Patients: effects on peritoneal transport and peritoneal defence - Paricalcitol in PD
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Verstoring peritoneale homeostase door peritoneaaldialyse
- Sponsor
- Vrije Universiteit Medisch Centrum
- Enrollment
- 24
- Status
- Completed
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •· the patient must provide written consent prior to starting the study
- •· patients must be over 18 years of age
- •· patients must have CKD stage 5 and treatment with peritoneal dialysis
- •· indication for active vitamin D therapy based on prevailing guidelines (after 6 weeks of wash\-out)
- •· Calcium, corrected to albumen, \< 2\.6 mmol/l (after 6 weeks of wash\-out)
- •· Not expected to receive a living donor transplant \< 6 months
Exclusion Criteria
- •· Patients who do not meet the specific inclusion criteria.
- •· UF \< 1000 ml/24h with 4 3\.86%/4\.25% glucose exchanges or impossibility to stop Extraneal
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Not Applicable
se of Calcimimetics vs oral Paricalcitol in Renal transplant Patients affected with Persistent Secondary Hyperparathyroidism. A pilot study - NDRenal transplant patientsMedDRA version: 9.1Level: LLTClassification code 10020708EUCTR2010-021041-42-ITAZIENDA UNIVERSITARIA POLICLINICO UMBERTO I DI ROMA
Completed
Phase 1
Perioperative versus Postoperative Oral Calcium and Vitamin D Supplement to Prevent Symptomatic Hypocalcemia after Total Thyroidectomy: A Randomized Controlled TrialPatients who underwent total or completion thyroidectomy from June 1st, 2017 to June 30th, 2020 at the department of otolaryngology, Maharaj Nakorn Chiang Mai HospitalThyroidectomy, Hypocalcemia, Calcium, Vitamin DTCTR20200622005one160
Completed
Not Applicable
Comparing one new treatment calcipotriol cream with old coaltar ointment in patients with chronic plaque psoriasisCTRI/2013/02/003384Chattrapati Shivaji Hospital Subharti Medical college60
Active, not recruiting
Not Applicable
Efficacy and safety of paricalcitol in the reduction of secondary hyperparathyroidism after kidney transplantation.Secondary hyperparathyroidism after renal transplantationMedDRA version: 16.0Level: PTClassification code 10020708Term: Hyperparathyroidism secondarySystem Organ Class: 10014698 - Endocrine disordersTherapeutic area: Diseases [C] - Hormonal diseases [C19]EUCTR2013-001326-25-ESFundación SENEFRO
Completed
Phase 2
Effect of oral calcitriol pulse therapy in comparison with oral daily calcitriol method in hemodiyalis paitientsSecondary hyperparathyroidism of renal origin.Secondary hyperparathyroidism of renal originGB90.4IRCT20111024007892N10Mashhad University of Medical Sciences20